DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,733,807 | +4.4% | 15,050 | +1.0% | 0.35% | -1.4% |
| Q2 2023 | $3,577,800 | -22.7% | 14,907 | -18.8% | 0.36% | -29.1% |
| Q1 2023 | $4,625,762 | -32.3% | 18,353 | -28.8% | 0.50% | -38.5% |
| Q4 2022 | $6,836,938 | -7.9% | 25,759 | -10.4% | 0.82% | -14.6% |
| Q3 2022 | $7,427,000 | +1.9% | 28,755 | +0.1% | 0.96% | +2.1% |
| Q2 2022 | $7,285,000 | -13.6% | 28,735 | -0.1% | 0.94% | +12.1% |
| Q1 2022 | $8,436,000 | -8.7% | 28,758 | +2.4% | 0.83% | -13.8% |
| Q4 2021 | $9,236,000 | +4.4% | 28,072 | -3.4% | 0.97% | -10.9% |
| Q3 2021 | $8,846,000 | +17.2% | 29,058 | +3.3% | 1.09% | +8.3% |
| Q2 2021 | $7,549,000 | +19.4% | 28,128 | +0.1% | 1.00% | +4.0% |
| Q1 2021 | $6,323,000 | -5.9% | 28,094 | -7.2% | 0.96% | -17.5% |
| Q4 2020 | $6,722,000 | -1.2% | 30,262 | -4.3% | 1.17% | -11.1% |
| Q3 2020 | $6,806,000 | +21.0% | 31,606 | -0.6% | 1.31% | +2.6% |
| Q2 2020 | $5,624,000 | +25.5% | 31,805 | -1.8% | 1.28% | +2.5% |
| Q1 2020 | $4,483,000 | – | 32,389 | – | 1.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |